In Brief: ThermoTrex Corp.
This article was originally published in The Gray Sheet
Executive SummaryThermoTrex Corp.: Mammography and stereotactic needle biopsy manufacturer names Gary Weinstein chairman and CEO effective Feb. 26. Weinstein, presently head of Lehman Brothers' global syndicate and equity capital markets group, will fill posts held by Firooz Rufeh, who will remain in the positions of president of ThermoTrex and VP of parent company Thermo Electron. Weinstein also is named a VP of Thermo Electron. Rufeh, who oversaw ThermoTrex' 1991 initial public offering as well as the 1994 IPO of its ThermoLase subsidiary, will "concentrate on strategic planning, technology development, and acquisitions for ThermoTrex and Thermo Electron," according to a release...
You may also be interested in...
The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.
The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings.
Hikma and Civica Rx have announced the launch of a first wave of eight essential injectable medicines, including heparin, as part of a deal struck between the two firms earlier this year.